85.76% from Q1 year 2017. The reason was the delay on the shipment to customers in the first two months of year 2018. The main raw materials’ crop, which is sweet corn, was delayed due to the weather. The
production and able to shipment on time which made company’s selling volume increased. Cost of Sales for Q1 / 2023 and Q1 / 2022 was 432.19 million baht and 290.96 million baht, respectively. It increased
5.9% Q-o-Q, but a reduction of 0.6% Y-o-Y. Total Sales revenue in USD terms grew by 5.8% Q-o-Q and 7.6% Y-o-Y, while PCB shipment value raised 6.55% Q-o-Q and 9.89% Y-o-Y (Table 5). The Y-o-Y Sales
FinancialStatement 56-1 56-2 Ranking BIS Bioscience Animal Health Public Company Limited Filing FinancialStatement 56-1 56-2 Ranking BCT BIRLA CARBON (THAILAND) PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56
in capacity utilization of Phase 3 at the new plant, but sales dropped in the following 2H18 (Table 4, PCB shipment value dropped 13% Q-o-Q in 4Q18) due to the typical low season and the effect of the
, property, plant and equipment increased by Baht 76.42 million which was new machines that ordered since last year but the shipment delayed until the early of this year and there was some capital expenditure
shipment delayed until the early of this year and were the investment for machine and equipment improvement. As of 30 September 2017 the Company had consolidated liabilities increased from last year by Baht
that ordered since last year but the shipment delayed until the early of this year and were the investment for machine and equipment improvement. As at 31 December 2017, the consolidated liabilities of
distribution of sugar and molasses business effect to Thailand and Global ,have an impact on revenue from sale decrease and postpone shipment from Export in first quarter . This situation have an impact on
775.9 -13.0 รวมไตรมาส 1 777.5 802.1 -24.6 797.9 675.4 122.5 ตารางที 4: ยอดขายและปริมาณขายตามภูมศิาสตร์ (PCB shipment @ ราคา Factory price) ตารางที 5: ยอดขายและปริมาณขายตามประเภทผลิตภณัฑ์ (PCB Shipment